Request Free Sample
×
GCC Acute Pancreatitis Market
ID: MRFR/HC/54721-HCR
200 Pages
February 2026
GCC Acute Pancreatitis Market Research Report: By Cause (Gallstones, Alcohol, Others), By Treatment (Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Others), By Diagnosis (Imaging Tests, Laboratory Tests) andBy End-User (Hospitals, Clinics, Others)- Forecast to 2035
Industry Developments
The GCC Acute Pancreatitis Market has recently witnessed significant developments, particularly with the rising prevalence of pancreatitis linked to lifestyle-related factors. In September 2023, Eli Lilly and Company announced advancements in therapeutic options, enhancing the management of acute pancreatitis through their innovative treatments. Medtronic has also been actively involved in providing critical medical devices aimed at improving patient outcomes in the region. The demand for nutritional support, which is crucial for recovery, has spiked, benefiting companies like Fresenius Kabi and Abbott Laboratories, who are expanding their product lines tailored for pancreatitis patients.In terms of mergers and acquisitions, there have not been any publicly reported transactions involving the specified companies within the last few months. However, the market has shown a marked increase in valuations due to improved awareness and treatment protocols for acute pancreatitis, positively impacting growth potential. Notable trends from the past two years, particularly in 2022, include a greater focus on patient education and early intervention strategies across the GCC healthcare systems, reflected in regional health initiatives aimed at improving healthcare delivery for pancreatitis management.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 294.0(USD Million) |
| MARKET SIZE 2024 | 314.5(USD Million) |
| MARKET SIZE 2035 | 1507.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 15.312% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Eli Lilly and Company, Medtronic, Fresenius Kabi, Abbott Laboratories, Boehringer Ingelheim, Thermo Fisher Scientific, Johnson & Johnson, Mylan, Novartis, Covidien, Amgen, Smith & Nephew, Stryker Corporation, Baxter International, Boston Scientific |
| SEGMENTS COVERED | Cause, Treatment, Diagnosis, End-User |
| KEY MARKET OPPORTUNITIES | Increasing incidence rates, Advancements in diagnostic technologies, Growth in healthcare infrastructure, Rising awareness and education, Expanding therapeutic options |
| KEY MARKET DYNAMICS | rising prevalence of obesity, increasing alcohol consumption, advancements in diagnostic tools, improved healthcare infrastructure, growing awareness of pancreatitis |
| COUNTRIES COVERED | GCC |
Leave a Comment
FAQs
What is the expected market size of the GCC Acute Pancreatitis Market in 2024?
The GCC Acute Pancreatitis Market is expected to be valued at 314.5 USD Million in 2024.
What is the projected market value of the GCC Acute Pancreatitis Market by 2035?
By 2035, the GCC Acute Pancreatitis Market is projected to reach a value of 1507.5 USD Million.
What is the expected compound annual growth rate (CAGR) for the GCC Acute Pancreatitis Market from 2025 to 2035?
The expected CAGR for the GCC Acute Pancreatitis Market from 2025 to 2035 is 15.312%.
Which cause segment is expected to dominate the GCC Acute Pancreatitis Market in 2024?
In 2024, the gallstones segment is expected to dominate the market with a valuation of 120.0 USD Million.
How much is the alcohol-related segment of the GCC Acute Pancreatitis Market valued at in 2024?
The alcohol-related segment of the GCC Acute Pancreatitis Market is valued at 110.0 USD Million in 2024.
What is the expected market value for the 'Others' cause segment in 2024?
The 'Others' cause segment of the GCC Acute Pancreatitis Market is expected to be valued at 84.5 USD Million in 2024.
Which key players are active in the GCC Acute Pancreatitis Market?
Major players in the GCC Acute Pancreatitis Market include Eli Lilly and Company, Medtronic, and Fresenius Kabi among others.
What is the market growth rate for gallstones in the GCC Acute Pancreatitis Market from 2025 to 2035?
The gallstones segment is projected to grow to 600.0 USD Million by 2035, indicating significant growth during the forecast period.
How much is the alcohol segment expected to grow by 2035?
By 2035, the alcohol segment is expected to grow to 550.0 USD Million, showcasing its growth potential in the market.
What are the emerging trends driving the growth of the GCC Acute Pancreatitis Market?
Emerging trends include increasing awareness of pancreatic health and advancements in treatment technologies, driving market growth.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense